Can't sue the big pharma reaper...


Merck cleared in Vioxx drug case

See, the trouble here is that Merck knew that Vioxx doubled the risk of heart attacks and finally, after pressure, and testimony from a FDA official, they pulled it. Now, magically, the 2nd lawsuit has failed, even though the first lawsuit ruling was in favor of the man who died as a result of taking Vioxx.

Merck shares rose $2.09 to $30.50 on New York's Stock Exchange on the news.

Enough said...